Pulse Biosciences (PLSE) Income towards Parent Company (2021 - 2025)
Historic Income towards Parent Company for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to -$19.4 million.
- Pulse Biosciences' Income towards Parent Company fell 5272.87% to -$19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.7 million, marking a year-over-year decrease of 6195.35%. This contributed to the annual value of -$53.6 million for FY2024, which is 2694.86% down from last year.
- Latest data reveals that Pulse Biosciences reported Income towards Parent Company of -$19.4 million as of Q3 2025, which was down 5272.87% from -$19.2 million recorded in Q2 2025.
- Pulse Biosciences' Income towards Parent Company's 5-year high stood at -$9.2 million during Q4 2022, with a 5-year trough of -$19.4 million in Q4 2024.
- Over the past 5 years, Pulse Biosciences' median Income towards Parent Company value was -$14.0 million (recorded in 2022), while the average stood at -$14.1 million.
- As far as peak fluctuations go, Pulse Biosciences' Income towards Parent Company skyrocketed by 4325.83% in 2023, and later plummeted by 6839.15% in 2025.
- Quarter analysis of 5 years shows Pulse Biosciences' Income towards Parent Company stood at -$15.4 million in 2021, then soared by 40.34% to -$9.2 million in 2022, then decreased by 29.75% to -$11.9 million in 2023, then plummeted by 62.45% to -$19.4 million in 2024, then increased by 0.1% to -$19.4 million in 2025.
- Its last three reported values are -$19.4 million in Q3 2025, -$19.2 million for Q2 2025, and -$16.8 million during Q1 2025.